Institutional Ownership Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX). We have compiled data on the 88 institutions that hold shares in the stock, with a total of 123 Million shares, which have been reported (via 13F filing form) to have a value of $258 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
4,771
shares
|
$10,019
0.0% of portfolio
|
Q2 2025
Reduced 98.97%
|
|
|
Private Wealth Asset Management, LLC
Cedar Rapids, IA |
Jul 28, 2025 Q2 2025 |
4,000
shares
|
$8,400
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Caitong International Asset Management Co., LTD
Hong Kong, K3 |
Jul 31, 2025 Q2 2025 |
1,656
shares
|
$3,477
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
398
shares
|
$835
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Aug 07, 2025 Q2 2025 |
84
shares
|
$176
0.0% of portfolio
|
Q2 2025
Reduced 22.22%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2
shares
|
$4
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|